REGISTERED NUMBER: 14414761 (England and Wales)

Unaudited Financial Statements for the Year Ended 31 October 2025

for

Trw Cardiac Diagnostics Limited

Page

Company Information

1

Balance Sheet

2

DIRECTOR:

T Whiteley

REGISTERED OFFICE:

57 Whirlowdale Crescent

Millhouses

Sheffield

S7 2NB

REGISTERED NUMBER:

14414761 (England and Wales)

FIXED ASSETS

118

349

CURRENT ASSETS

56,775

61,131

CREDITORS

Amounts falling due within one year

(22,638

)

(20,576

)

NET CURRENT ASSETS

34,137

40,555

TOTAL ASSETS LESS CURRENT LIABILITIES

34,255

40,904

CAPITAL AND RESERVES

34,255

40,904

NOTES TO THE FINANCIAL STATEMENTS

1.	AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 1 (2024 - 1 ) .

2.	DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 October 2025 and 31 October 2024:

31.10.25

31.10.24

£

£

T Whiteley

Balance outstanding at start of year

36

162

Amounts repaid

(36

)

(126

)

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

-

36

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 October 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 October 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 28 January 2026 and were signed by:

T Whiteley - Director